nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1D—meninx—germ cell cancer	0.0405	0.0558	CbGeAlD
Methysergide—HTR1F—trigeminal nerve—germ cell cancer	0.0404	0.0556	CbGeAlD
Methysergide—HTR1B—dura mater—germ cell cancer	0.0385	0.053	CbGeAlD
Methysergide—HTR1D—dura mater—germ cell cancer	0.0373	0.0513	CbGeAlD
Methysergide—HTR2B—cardial valve—germ cell cancer	0.0366	0.0504	CbGeAlD
Methysergide—HTR2C—choroid plexus—germ cell cancer	0.0314	0.0432	CbGeAlD
Methysergide—HTR7—superior cervical ganglion—germ cell cancer	0.0226	0.0311	CbGeAlD
Methysergide—HTR2A—phrenic nerve—germ cell cancer	0.0218	0.03	CbGeAlD
Methysergide—HTR7—myenteric nerve plexus—germ cell cancer	0.0179	0.0247	CbGeAlD
Methysergide—HTR1B—trigeminal nerve—germ cell cancer	0.0166	0.0228	CbGeAlD
Methysergide—HTR1D—trigeminal nerve—germ cell cancer	0.016	0.0221	CbGeAlD
Methysergide—HTR2A—choroid plexus—germ cell cancer	0.0158	0.0217	CbGeAlD
Methysergide—HTR1F—ganglion—germ cell cancer	0.0146	0.0201	CbGeAlD
Methysergide—HTR7—vagus nerve—germ cell cancer	0.012	0.0164	CbGeAlD
Methysergide—HTR1B—cranial nerve—germ cell cancer	0.0118	0.0162	CbGeAlD
Methysergide—HTR1D—cranial nerve—germ cell cancer	0.0114	0.0157	CbGeAlD
Methysergide—HTR2A—myenteric nerve plexus—germ cell cancer	0.0112	0.0154	CbGeAlD
Methysergide—HTR6—ganglion—germ cell cancer	0.00991	0.0136	CbGeAlD
Methysergide—HTR1B—telencephalic ventricle—germ cell cancer	0.0096	0.0132	CbGeAlD
Methysergide—HTR1D—telencephalic ventricle—germ cell cancer	0.00929	0.0128	CbGeAlD
Methysergide—HTR2C—telencephalic ventricle—germ cell cancer	0.0092	0.0127	CbGeAlD
Methysergide—HTR7—cranial nerve—germ cell cancer	0.00911	0.0125	CbGeAlD
Methysergide—HTR7—pons—germ cell cancer	0.009	0.0124	CbGeAlD
Methysergide—Telangiectasia—Methotrexate—germ cell cancer	0.00843	0.0309	CcSEcCtD
Methysergide—HTR2A—trigeminal nerve—germ cell cancer	0.00797	0.011	CbGeAlD
Methysergide—HTR1A—telencephalic ventricle—germ cell cancer	0.00775	0.0107	CbGeAlD
Methysergide—HTR2A—vagus nerve—germ cell cancer	0.00745	0.0103	CbGeAlD
Methysergide—HTR7—telencephalic ventricle—germ cell cancer	0.0074	0.0102	CbGeAlD
Methysergide—Hyperaesthesia—Bleomycin—germ cell cancer	0.00626	0.0229	CcSEcCtD
Methysergide—HTR1B—ganglion—germ cell cancer	0.00598	0.00822	CbGeAlD
Methysergide—HTR1D—ganglion—germ cell cancer	0.00579	0.00796	CbGeAlD
Methysergide—HTR2C—ganglion—germ cell cancer	0.00573	0.00788	CbGeAlD
Methysergide—HTR2A—cranial nerve—germ cell cancer	0.00568	0.00781	CbGeAlD
Methysergide—HTR1F—telencephalon—germ cell cancer	0.00563	0.00774	CbGeAlD
Methysergide—HTR2A—pons—germ cell cancer	0.00561	0.00772	CbGeAlD
Methysergide—HTR1E—brainstem—germ cell cancer	0.00549	0.00755	CbGeAlD
Methysergide—Pleural effusion—Ifosfamide—germ cell cancer	0.00548	0.0201	CcSEcCtD
Methysergide—HTR1E—telencephalon—germ cell cancer	0.00487	0.0067	CbGeAlD
Methysergide—HTR1A—ganglion—germ cell cancer	0.00482	0.00663	CbGeAlD
Methysergide—HTR1B—blood vessel—germ cell cancer	0.00475	0.00654	CbGeAlD
Methysergide—HTR2A—telencephalic ventricle—germ cell cancer	0.00462	0.00635	CbGeAlD
Methysergide—HTR7—ganglion—germ cell cancer	0.00461	0.00634	CbGeAlD
Methysergide—HTR1D—blood vessel—germ cell cancer	0.0046	0.00633	CbGeAlD
Methysergide—HTR2A—urine—germ cell cancer	0.00422	0.0058	CbGeAlD
Methysergide—HTR2A—appendage—germ cell cancer	0.00411	0.00565	CbGeAlD
Methysergide—HTR2A—pineal body—germ cell cancer	0.00401	0.00551	CbGeAlD
Methysergide—HTR7—endothelium—germ cell cancer	0.00397	0.00547	CbGeAlD
Methysergide—HTR6—telencephalon—germ cell cancer	0.00382	0.00526	CbGeAlD
Methysergide—Urine output increased—Ifosfamide—germ cell cancer	0.0038	0.0139	CcSEcCtD
Methysergide—HTR7—blood vessel—germ cell cancer	0.00366	0.00504	CbGeAlD
Methysergide—Thrombophlebitis—Ifosfamide—germ cell cancer	0.00352	0.0129	CcSEcCtD
Methysergide—HTR1F—head—germ cell cancer	0.0035	0.00482	CbGeAlD
Methysergide—Polyuria—Ifosfamide—germ cell cancer	0.00347	0.0127	CcSEcCtD
Methysergide—HTR1E—female gonad—germ cell cancer	0.00331	0.00455	CbGeAlD
Methysergide—Pain in extremity—Ifosfamide—germ cell cancer	0.00305	0.0112	CcSEcCtD
Methysergide—HTR1E—head—germ cell cancer	0.00304	0.00417	CbGeAlD
Methysergide—Polyuria—Cisplatin—germ cell cancer	0.00299	0.011	CcSEcCtD
Methysergide—HTR1B—trigeminal ganglion—germ cell cancer	0.00294	0.00404	CbGeAlD
Methysergide—HTR2A—ganglion—germ cell cancer	0.00287	0.00395	CbGeAlD
Methysergide—HTR1D—trigeminal ganglion—germ cell cancer	0.00284	0.00391	CbGeAlD
Methysergide—Weight decreased—Bleomycin—germ cell cancer	0.00279	0.0102	CcSEcCtD
Methysergide—Neutropenia—Dactinomycin—germ cell cancer	0.00269	0.00985	CcSEcCtD
Methysergide—SIGMAR1—trigeminal ganglion—germ cell cancer	0.00265	0.00364	CbGeAlD
Methysergide—HTR7—neck—germ cell cancer	0.00262	0.00361	CbGeAlD
Methysergide—HTR1B—brainstem—germ cell cancer	0.0026	0.00357	CbGeAlD
Methysergide—Pleural effusion—Methotrexate—germ cell cancer	0.00259	0.00951	CcSEcCtD
Methysergide—Alopecia—Vinblastine—germ cell cancer	0.00258	0.00946	CcSEcCtD
Methysergide—HTR1F—brain—germ cell cancer	0.00254	0.00349	CbGeAlD
Methysergide—HTR1D—brainstem—germ cell cancer	0.00251	0.00346	CbGeAlD
Methysergide—HTR2C—brainstem—germ cell cancer	0.00249	0.00343	CbGeAlD
Methysergide—HTR2A—endothelium—germ cell cancer	0.00248	0.00341	CbGeAlD
Methysergide—Dysuria—Ifosfamide—germ cell cancer	0.00246	0.00903	CcSEcCtD
Methysergide—HTR1D—eye—germ cell cancer	0.00245	0.00337	CbGeAlD
Methysergide—Orthostatic hypotension—Cisplatin—germ cell cancer	0.0024	0.0088	CcSEcCtD
Methysergide—HTR6—head—germ cell cancer	0.00238	0.00328	CbGeAlD
Methysergide—Ill-defined disorder—Vinblastine—germ cell cancer	0.00236	0.00865	CcSEcCtD
Methysergide—HTR1B—telencephalon—germ cell cancer	0.00231	0.00317	CbGeAlD
Methysergide—Malaise—Vinblastine—germ cell cancer	0.00229	0.0084	CcSEcCtD
Methysergide—Flushing—Bleomycin—germ cell cancer	0.00229	0.00839	CcSEcCtD
Methysergide—HTR2A—blood vessel—germ cell cancer	0.00229	0.00314	CbGeAlD
Methysergide—SIGMAR1—eye—germ cell cancer	0.00228	0.00314	CbGeAlD
Methysergide—HTR1D—telencephalon—germ cell cancer	0.00223	0.00307	CbGeAlD
Methysergide—HTR2C—telencephalon—germ cell cancer	0.00221	0.00304	CbGeAlD
Methysergide—Convulsion—Vinblastine—germ cell cancer	0.0022	0.00807	CcSEcCtD
Methysergide—HTR1E—brain—germ cell cancer	0.0022	0.00303	CbGeAlD
Methysergide—Alopecia—Bleomycin—germ cell cancer	0.00218	0.00799	CcSEcCtD
Methysergide—Oliguria—Methotrexate—germ cell cancer	0.00216	0.0079	CcSEcCtD
Methysergide—Discomfort—Vinblastine—germ cell cancer	0.00214	0.00784	CcSEcCtD
Methysergide—Flushing—Dactinomycin—germ cell cancer	0.00214	0.00783	CcSEcCtD
Methysergide—HTR1A—brainstem—germ cell cancer	0.0021	0.00288	CbGeAlD
Methysergide—SIGMAR1—telencephalon—germ cell cancer	0.00208	0.00286	CbGeAlD
Methysergide—HTR2B—telencephalon—germ cell cancer	0.00208	0.00286	CbGeAlD
Methysergide—Alopecia—Dactinomycin—germ cell cancer	0.00203	0.00745	CcSEcCtD
Methysergide—Thrombocytopenia—Vinblastine—germ cell cancer	0.00203	0.00745	CcSEcCtD
Methysergide—HTR7—brainstem—germ cell cancer	0.002	0.00276	CbGeAlD
Methysergide—Ill-defined disorder—Bleomycin—germ cell cancer	0.00199	0.0073	CcSEcCtD
Methysergide—HTR2B—skin of body—germ cell cancer	0.00198	0.00273	CbGeAlD
Methysergide—SIGMAR1—decidua—germ cell cancer	0.00197	0.00271	CbGeAlD
Methysergide—HTR2B—decidua—germ cell cancer	0.00197	0.00271	CbGeAlD
Methysergide—Flushing—Ifosfamide—germ cell cancer	0.00196	0.00717	CcSEcCtD
Methysergide—Neutropenia—Etoposide—germ cell cancer	0.00195	0.00713	CcSEcCtD
Methysergide—Malaise—Bleomycin—germ cell cancer	0.00194	0.0071	CcSEcCtD
Methysergide—Paraesthesia—Vinblastine—germ cell cancer	0.00186	0.00683	CcSEcCtD
Methysergide—Alopecia—Ifosfamide—germ cell cancer	0.00186	0.00683	CcSEcCtD
Methysergide—HTR1A—telencephalon—germ cell cancer	0.00186	0.00256	CbGeAlD
Methysergide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00186	0.00681	CcSEcCtD
Methysergide—Myalgia—Bleomycin—germ cell cancer	0.00183	0.0067	CcSEcCtD
Methysergide—Chest pain—Bleomycin—germ cell cancer	0.00183	0.0067	CcSEcCtD
Methysergide—Discomfort—Bleomycin—germ cell cancer	0.00181	0.00662	CcSEcCtD
Methysergide—Malaise—Dactinomycin—germ cell cancer	0.00181	0.00662	CcSEcCtD
Methysergide—Urine output increased—Methotrexate—germ cell cancer	0.0018	0.00658	CcSEcCtD
Methysergide—HTR7—telencephalon—germ cell cancer	0.00178	0.00245	CbGeAlD
Methysergide—Constipation—Vinblastine—germ cell cancer	0.00178	0.0065	CcSEcCtD
Methysergide—Pain—Vinblastine—germ cell cancer	0.00178	0.0065	CcSEcCtD
Methysergide—Oedema—Bleomycin—germ cell cancer	0.00175	0.00642	CcSEcCtD
Methysergide—HTR2C—medulla oblongata—germ cell cancer	0.00174	0.00239	CbGeAlD
Methysergide—HTR6—brain—germ cell cancer	0.00173	0.00237	CbGeAlD
Methysergide—SIGMAR1—uterus—germ cell cancer	0.00173	0.00237	CbGeAlD
Methysergide—HTR2B—uterus—germ cell cancer	0.00172	0.00237	CbGeAlD
Methysergide—Thrombocytopenia—Bleomycin—germ cell cancer	0.00172	0.00629	CcSEcCtD
Methysergide—Feeling abnormal—Vinblastine—germ cell cancer	0.00171	0.00627	CcSEcCtD
Methysergide—Myalgia—Dactinomycin—germ cell cancer	0.00171	0.00625	CcSEcCtD
Methysergide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.0017	0.00624	CcSEcCtD
Methysergide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.0017	0.00622	CcSEcCtD
Methysergide—SIGMAR1—pituitary gland—germ cell cancer	0.00169	0.00233	CbGeAlD
Methysergide—Flushing—Cisplatin—germ cell cancer	0.00169	0.00618	CcSEcCtD
Methysergide—Discomfort—Dactinomycin—germ cell cancer	0.00169	0.00617	CcSEcCtD
Methysergide—Thrombophlebitis—Methotrexate—germ cell cancer	0.00167	0.0061	CcSEcCtD
Methysergide—Malaise—Ifosfamide—germ cell cancer	0.00166	0.00607	CcSEcCtD
Methysergide—HTR1B—midbrain—germ cell cancer	0.00166	0.00228	CbGeAlD
Methysergide—Polyuria—Methotrexate—germ cell cancer	0.00164	0.00602	CcSEcCtD
Methysergide—Abdominal pain—Vinblastine—germ cell cancer	0.00164	0.00601	CcSEcCtD
Methysergide—Oedema—Dactinomycin—germ cell cancer	0.00164	0.00599	CcSEcCtD
Methysergide—SIGMAR1—medulla oblongata—germ cell cancer	0.00164	0.00225	CbGeAlD
Methysergide—HTR2A—neck—germ cell cancer	0.00163	0.00225	CbGeAlD
Methysergide—HTR1B—spinal cord—germ cell cancer	0.00162	0.00222	CbGeAlD
Methysergide—Alopecia—Cisplatin—germ cell cancer	0.00161	0.00589	CcSEcCtD
Methysergide—HTR1D—midbrain—germ cell cancer	0.0016	0.0022	CbGeAlD
Methysergide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.0016	0.00587	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.0016	0.00585	CcSEcCtD
Methysergide—Convulsion—Ifosfamide—germ cell cancer	0.00159	0.00583	CcSEcCtD
Methysergide—HTR2C—midbrain—germ cell cancer	0.00159	0.00218	CbGeAlD
Methysergide—Paraesthesia—Bleomycin—germ cell cancer	0.00157	0.00577	CcSEcCtD
Methysergide—Dyspnoea—Bleomycin—germ cell cancer	0.00156	0.00573	CcSEcCtD
Methysergide—Myalgia—Ifosfamide—germ cell cancer	0.00156	0.00573	CcSEcCtD
Methysergide—Arthralgia—Ifosfamide—germ cell cancer	0.00156	0.00573	CcSEcCtD
Methysergide—Chest pain—Ifosfamide—germ cell cancer	0.00156	0.00573	CcSEcCtD
Methysergide—HTR2C—spinal cord—germ cell cancer	0.00155	0.00213	CbGeAlD
Methysergide—Flushing—Etoposide—germ cell cancer	0.00155	0.00566	CcSEcCtD
Methysergide—Discomfort—Ifosfamide—germ cell cancer	0.00154	0.00566	CcSEcCtD
Methysergide—SIGMAR1—adrenal gland—germ cell cancer	0.00151	0.00208	CbGeAlD
Methysergide—HTR2B—adrenal gland—germ cell cancer	0.00151	0.00208	CbGeAlD
Methysergide—Pain—Bleomycin—germ cell cancer	0.0015	0.00549	CcSEcCtD
Methysergide—Oedema—Ifosfamide—germ cell cancer	0.0015	0.00549	CcSEcCtD
Methysergide—SIGMAR1—midbrain—germ cell cancer	0.00149	0.00206	CbGeAlD
Methysergide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00149	0.00546	CcSEcCtD
Methysergide—Asthenia—Vinblastine—germ cell cancer	0.00149	0.00546	CcSEcCtD
Methysergide—HTR7—gonad—germ cell cancer	0.00148	0.00204	CbGeAlD
Methysergide—Alopecia—Etoposide—germ cell cancer	0.00147	0.00539	CcSEcCtD
Methysergide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00147	0.00538	CcSEcCtD
Methysergide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00147	0.00538	CcSEcCtD
Methysergide—SIGMAR1—bone marrow—germ cell cancer	0.00146	0.00201	CbGeAlD
Methysergide—SIGMAR1—spinal cord—germ cell cancer	0.00146	0.00201	CbGeAlD
Methysergide—HTR1B—endocrine gland—germ cell cancer	0.00145	0.002	CbGeAlD
Methysergide—Feeling abnormal—Bleomycin—germ cell cancer	0.00144	0.00529	CcSEcCtD
Methysergide—HTR1B—head—germ cell cancer	0.00144	0.00197	CbGeAlD
Methysergide—Malaise—Cisplatin—germ cell cancer	0.00143	0.00523	CcSEcCtD
Methysergide—Diarrhoea—Vinblastine—germ cell cancer	0.00142	0.0052	CcSEcCtD
Methysergide—SIGMAR1—female gonad—germ cell cancer	0.00141	0.00194	CbGeAlD
Methysergide—Fatigue—Dactinomycin—germ cell cancer	0.00141	0.00517	CcSEcCtD
Methysergide—Back pain—Etoposide—germ cell cancer	0.0014	0.00514	CcSEcCtD
Methysergide—Pain—Dactinomycin—germ cell cancer	0.0014	0.00512	CcSEcCtD
Methysergide—HTR7—medulla oblongata—germ cell cancer	0.0014	0.00192	CbGeAlD
Methysergide—HTR1D—head—germ cell cancer	0.00139	0.00191	CbGeAlD
Methysergide—Body temperature increased—Bleomycin—germ cell cancer	0.00139	0.00508	CcSEcCtD
Methysergide—HTR2C—head—germ cell cancer	0.00138	0.00189	CbGeAlD
Methysergide—Dizziness—Vinblastine—germ cell cancer	0.00137	0.00503	CcSEcCtD
Methysergide—Convulsion—Cisplatin—germ cell cancer	0.00137	0.00502	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00137	0.005	CcSEcCtD
Methysergide—HTR2A—embryo—germ cell cancer	0.00136	0.00187	CbGeAlD
Methysergide—Ataxia—Methotrexate—germ cell cancer	0.00136	0.00497	CcSEcCtD
Methysergide—HTR1A—adrenal gland—germ cell cancer	0.00135	0.00186	CbGeAlD
Methysergide—Myalgia—Cisplatin—germ cell cancer	0.00135	0.00494	CcSEcCtD
Methysergide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00135	0.00494	CcSEcCtD
Methysergide—Paraesthesia—Ifosfamide—germ cell cancer	0.00135	0.00493	CcSEcCtD
Methysergide—Ill-defined disorder—Etoposide—germ cell cancer	0.00135	0.00493	CcSEcCtD
Methysergide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00134	0.0049	CcSEcCtD
Methysergide—HTR1A—midbrain—germ cell cancer	0.00134	0.00184	CbGeAlD
Methysergide—Dyspnoea—Ifosfamide—germ cell cancer	0.00134	0.00489	CcSEcCtD
Methysergide—Somnolence—Ifosfamide—germ cell cancer	0.00133	0.00488	CcSEcCtD
Methysergide—Discomfort—Cisplatin—germ cell cancer	0.00133	0.00488	CcSEcCtD
Methysergide—Vomiting—Vinblastine—germ cell cancer	0.00132	0.00484	CcSEcCtD
Methysergide—Malaise—Etoposide—germ cell cancer	0.00131	0.00479	CcSEcCtD
Methysergide—HTR1A—spinal cord—germ cell cancer	0.0013	0.00179	CbGeAlD
Methysergide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00129	0.00474	CcSEcCtD
Methysergide—HTR7—adrenal gland—germ cell cancer	0.00129	0.00178	CbGeAlD
Methysergide—HTR2B—head—germ cell cancer	0.00129	0.00178	CbGeAlD
Methysergide—Abdominal pain—Dactinomycin—germ cell cancer	0.00129	0.00474	CcSEcCtD
Methysergide—Body temperature increased—Dactinomycin—germ cell cancer	0.00129	0.00474	CcSEcCtD
Methysergide—Fatigue—Ifosfamide—germ cell cancer	0.00129	0.00473	CcSEcCtD
Methysergide—Oedema—Cisplatin—germ cell cancer	0.00129	0.00473	CcSEcCtD
Methysergide—Constipation—Ifosfamide—germ cell cancer	0.00128	0.00469	CcSEcCtD
Methysergide—Pain—Ifosfamide—germ cell cancer	0.00128	0.00469	CcSEcCtD
Methysergide—HTR7—midbrain—germ cell cancer	0.00128	0.00176	CbGeAlD
Methysergide—Thrombocytopenia—Cisplatin—germ cell cancer	0.00126	0.00463	CcSEcCtD
Methysergide—Tachycardia—Cisplatin—germ cell cancer	0.00126	0.00462	CcSEcCtD
Methysergide—Asthenia—Bleomycin—germ cell cancer	0.00126	0.00461	CcSEcCtD
Methysergide—Convulsion—Etoposide—germ cell cancer	0.00126	0.0046	CcSEcCtD
Methysergide—SIGMAR1—testis—germ cell cancer	0.00125	0.00172	CbGeAlD
Methysergide—HTR2A—brainstem—germ cell cancer	0.00125	0.00172	CbGeAlD
Methysergide—HTR7—spinal cord—germ cell cancer	0.00125	0.00171	CbGeAlD
Methysergide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00123	0.00452	CcSEcCtD
Methysergide—Chest pain—Etoposide—germ cell cancer	0.00123	0.00452	CcSEcCtD
Methysergide—Eosinophilia—Methotrexate—germ cell cancer	0.00123	0.00452	CcSEcCtD
Methysergide—Nausea—Vinblastine—germ cell cancer	0.00123	0.00452	CcSEcCtD
Methysergide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00123	0.00449	CcSEcCtD
Methysergide—Discomfort—Etoposide—germ cell cancer	0.00122	0.00447	CcSEcCtD
Methysergide—HTR2A—eye—germ cell cancer	0.00122	0.00167	CbGeAlD
Methysergide—HTR2A—retina—germ cell cancer	0.00121	0.00166	CbGeAlD
Methysergide—Abdominal pain—Ifosfamide—germ cell cancer	0.00118	0.00434	CcSEcCtD
Methysergide—Body temperature increased—Ifosfamide—germ cell cancer	0.00118	0.00434	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00118	0.00431	CcSEcCtD
Methysergide—HTR1A—endocrine gland—germ cell cancer	0.00117	0.00161	CbGeAlD
Methysergide—Asthenia—Dactinomycin—germ cell cancer	0.00117	0.0043	CcSEcCtD
Methysergide—Dysuria—Methotrexate—germ cell cancer	0.00117	0.00427	CcSEcCtD
Methysergide—Neutropenia—Methotrexate—germ cell cancer	0.00117	0.00427	CcSEcCtD
Methysergide—Paraesthesia—Cisplatin—germ cell cancer	0.00116	0.00425	CcSEcCtD
Methysergide—Thrombocytopenia—Etoposide—germ cell cancer	0.00116	0.00425	CcSEcCtD
Methysergide—HTR1A—head—germ cell cancer	0.00116	0.00159	CbGeAlD
Methysergide—SIGMAR1—cerebellum—germ cell cancer	0.00116	0.00159	CbGeAlD
Methysergide—Tachycardia—Etoposide—germ cell cancer	0.00116	0.00423	CcSEcCtD
Methysergide—Dyspnoea—Cisplatin—germ cell cancer	0.00115	0.00422	CcSEcCtD
Methysergide—HTR7—endocrine gland—germ cell cancer	0.00112	0.00154	CbGeAlD
Methysergide—Diarrhoea—Dactinomycin—germ cell cancer	0.00112	0.0041	CcSEcCtD
Methysergide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00112	0.00409	CcSEcCtD
Methysergide—Vomiting—Bleomycin—germ cell cancer	0.00111	0.00408	CcSEcCtD
Methysergide—Drowsiness—Methotrexate—germ cell cancer	0.00111	0.00407	CcSEcCtD
Methysergide—HTR2A—telencephalon—germ cell cancer	0.00111	0.00152	CbGeAlD
Methysergide—HTR7—head—germ cell cancer	0.00111	0.00152	CbGeAlD
Methysergide—Rash—Bleomycin—germ cell cancer	0.00111	0.00405	CcSEcCtD
Methysergide—Pain—Cisplatin—germ cell cancer	0.0011	0.00405	CcSEcCtD
Methysergide—Dermatitis—Bleomycin—germ cell cancer	0.0011	0.00405	CcSEcCtD
Methysergide—Asthenia—Ifosfamide—germ cell cancer	0.00108	0.00394	CcSEcCtD
Methysergide—HTR7—testis—germ cell cancer	0.00107	0.00147	CbGeAlD
Methysergide—Feeling abnormal—Cisplatin—germ cell cancer	0.00106	0.0039	CcSEcCtD
Methysergide—Paraesthesia—Etoposide—germ cell cancer	0.00106	0.00389	CcSEcCtD
Methysergide—Dyspnoea—Etoposide—germ cell cancer	0.00106	0.00387	CcSEcCtD
Methysergide—Somnolence—Etoposide—germ cell cancer	0.00105	0.00385	CcSEcCtD
Methysergide—Nausea—Bleomycin—germ cell cancer	0.00104	0.00382	CcSEcCtD
Methysergide—HTR1B—brain—germ cell cancer	0.00104	0.00143	CbGeAlD
Methysergide—Vomiting—Dactinomycin—germ cell cancer	0.00104	0.00381	CcSEcCtD
Methysergide—HTR1A—cerebellum—germ cell cancer	0.00103	0.00142	CbGeAlD
Methysergide—Rash—Dactinomycin—germ cell cancer	0.00103	0.00378	CcSEcCtD
Methysergide—Diarrhoea—Ifosfamide—germ cell cancer	0.00103	0.00376	CcSEcCtD
Methysergide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00102	0.00374	CcSEcCtD
Methysergide—Body temperature increased—Cisplatin—germ cell cancer	0.00102	0.00374	CcSEcCtD
Methysergide—Fatigue—Etoposide—germ cell cancer	0.00102	0.00374	CcSEcCtD
Methysergide—Pain—Etoposide—germ cell cancer	0.00101	0.00371	CcSEcCtD
Methysergide—Constipation—Etoposide—germ cell cancer	0.00101	0.00371	CcSEcCtD
Methysergide—HTR1D—brain—germ cell cancer	0.00101	0.00139	CbGeAlD
Methysergide—HTR2C—brain—germ cell cancer	0.000997	0.00137	CbGeAlD
Methysergide—Dizziness—Ifosfamide—germ cell cancer	0.000991	0.00363	CcSEcCtD
Methysergide—HTR7—cerebellum—germ cell cancer	0.000988	0.00136	CbGeAlD
Methysergide—Feeling abnormal—Etoposide—germ cell cancer	0.000975	0.00357	CcSEcCtD
Methysergide—Nausea—Dactinomycin—germ cell cancer	0.000971	0.00356	CcSEcCtD
Methysergide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000968	0.00355	CcSEcCtD
Methysergide—Vomiting—Ifosfamide—germ cell cancer	0.000953	0.00349	CcSEcCtD
Methysergide—Rash—Ifosfamide—germ cell cancer	0.000945	0.00346	CcSEcCtD
Methysergide—Dermatitis—Ifosfamide—germ cell cancer	0.000944	0.00346	CcSEcCtD
Methysergide—SIGMAR1—brain—germ cell cancer	0.000939	0.00129	CbGeAlD
Methysergide—HTR2B—brain—germ cell cancer	0.000937	0.00129	CbGeAlD
Methysergide—Abdominal pain—Etoposide—germ cell cancer	0.000936	0.00343	CcSEcCtD
Methysergide—Body temperature increased—Etoposide—germ cell cancer	0.000936	0.00343	CcSEcCtD
Methysergide—Asthenia—Cisplatin—germ cell cancer	0.000927	0.0034	CcSEcCtD
Methysergide—HTR2A—gonad—germ cell cancer	0.000925	0.00127	CbGeAlD
Methysergide—SIGMAR1—lymph node—germ cell cancer	0.000907	0.00125	CbGeAlD
Methysergide—HTR2B—lymph node—germ cell cancer	0.000905	0.00125	CbGeAlD
Methysergide—HTR2A—pituitary gland—germ cell cancer	0.000903	0.00124	CbGeAlD
Methysergide—Nausea—Ifosfamide—germ cell cancer	0.00089	0.00326	CcSEcCtD
Methysergide—Diarrhoea—Cisplatin—germ cell cancer	0.000884	0.00324	CcSEcCtD
Methysergide—Alopecia—Methotrexate—germ cell cancer	0.000882	0.00323	CcSEcCtD
Methysergide—HTR2A—medulla oblongata—germ cell cancer	0.000871	0.0012	CbGeAlD
Methysergide—Asthenia—Etoposide—germ cell cancer	0.000849	0.00311	CcSEcCtD
Methysergide—Back pain—Methotrexate—germ cell cancer	0.00084	0.00308	CcSEcCtD
Methysergide—HTR1A—brain—germ cell cancer	0.000839	0.00115	CbGeAlD
Methysergide—Vomiting—Cisplatin—germ cell cancer	0.000821	0.00301	CcSEcCtD
Methysergide—Rash—Cisplatin—germ cell cancer	0.000815	0.00298	CcSEcCtD
Methysergide—Dermatitis—Cisplatin—germ cell cancer	0.000814	0.00298	CcSEcCtD
Methysergide—Diarrhoea—Etoposide—germ cell cancer	0.00081	0.00297	CcSEcCtD
Methysergide—HTR2A—adrenal gland—germ cell cancer	0.000806	0.00111	CbGeAlD
Methysergide—Ill-defined disorder—Methotrexate—germ cell cancer	0.000806	0.00295	CcSEcCtD
Methysergide—HTR7—brain—germ cell cancer	0.000802	0.0011	CbGeAlD
Methysergide—HTR2A—midbrain—germ cell cancer	0.000796	0.0011	CbGeAlD
Methysergide—Malaise—Methotrexate—germ cell cancer	0.000783	0.00287	CcSEcCtD
Methysergide—Dizziness—Etoposide—germ cell cancer	0.000783	0.00287	CcSEcCtD
Methysergide—HTR2A—spinal cord—germ cell cancer	0.000777	0.00107	CbGeAlD
Methysergide—Nausea—Cisplatin—germ cell cancer	0.000767	0.00281	CcSEcCtD
Methysergide—Convulsion—Methotrexate—germ cell cancer	0.000753	0.00276	CcSEcCtD
Methysergide—Vomiting—Etoposide—germ cell cancer	0.000752	0.00276	CcSEcCtD
Methysergide—Rash—Etoposide—germ cell cancer	0.000746	0.00273	CcSEcCtD
Methysergide—Dermatitis—Etoposide—germ cell cancer	0.000746	0.00273	CcSEcCtD
Methysergide—Arthralgia—Methotrexate—germ cell cancer	0.000739	0.00271	CcSEcCtD
Methysergide—Chest pain—Methotrexate—germ cell cancer	0.000739	0.00271	CcSEcCtD
Methysergide—Myalgia—Methotrexate—germ cell cancer	0.000739	0.00271	CcSEcCtD
Methysergide—Discomfort—Methotrexate—germ cell cancer	0.000731	0.00268	CcSEcCtD
Methysergide—Nausea—Etoposide—germ cell cancer	0.000703	0.00258	CcSEcCtD
Methysergide—HTR2A—endocrine gland—germ cell cancer	0.000699	0.000962	CbGeAlD
Methysergide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000694	0.00254	CcSEcCtD
Methysergide—HTR2A—head—germ cell cancer	0.00069	0.00095	CbGeAlD
Methysergide—HTR2A—testis—germ cell cancer	0.000667	0.000917	CbGeAlD
Methysergide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000646	0.00237	CcSEcCtD
Methysergide—Insomnia—Methotrexate—germ cell cancer	0.000641	0.00235	CcSEcCtD
Methysergide—Paraesthesia—Methotrexate—germ cell cancer	0.000637	0.00233	CcSEcCtD
Methysergide—Dyspnoea—Methotrexate—germ cell cancer	0.000632	0.00232	CcSEcCtD
Methysergide—Somnolence—Methotrexate—germ cell cancer	0.00063	0.00231	CcSEcCtD
Methysergide—Dyspepsia—Methotrexate—germ cell cancer	0.000624	0.00229	CcSEcCtD
Methysergide—HTR2A—cerebellum—germ cell cancer	0.000616	0.000847	CbGeAlD
Methysergide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000612	0.00224	CcSEcCtD
Methysergide—Fatigue—Methotrexate—germ cell cancer	0.000611	0.00224	CcSEcCtD
Methysergide—Pain—Methotrexate—germ cell cancer	0.000606	0.00222	CcSEcCtD
Methysergide—Feeling abnormal—Methotrexate—germ cell cancer	0.000584	0.00214	CcSEcCtD
Methysergide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00058	0.00212	CcSEcCtD
Methysergide—Body temperature increased—Methotrexate—germ cell cancer	0.00056	0.00205	CcSEcCtD
Methysergide—Abdominal pain—Methotrexate—germ cell cancer	0.00056	0.00205	CcSEcCtD
Methysergide—Asthenia—Methotrexate—germ cell cancer	0.000509	0.00186	CcSEcCtD
Methysergide—HTR2A—brain—germ cell cancer	0.0005	0.000688	CbGeAlD
Methysergide—Diarrhoea—Methotrexate—germ cell cancer	0.000485	0.00178	CcSEcCtD
Methysergide—Dizziness—Methotrexate—germ cell cancer	0.000469	0.00172	CcSEcCtD
Methysergide—Vomiting—Methotrexate—germ cell cancer	0.000451	0.00165	CcSEcCtD
Methysergide—Rash—Methotrexate—germ cell cancer	0.000447	0.00164	CcSEcCtD
Methysergide—Dermatitis—Methotrexate—germ cell cancer	0.000447	0.00164	CcSEcCtD
Methysergide—Nausea—Methotrexate—germ cell cancer	0.000421	0.00154	CcSEcCtD
